Dayne Voelker is a Rheumatology/Immunology physician affiliated with Mayo Clinic. OpenAlex indexes 55 publications with 360 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Blueprint Medicines CorporationProgram year20253 payments$5,088
- SANOFI US SERVICES INC.Program year20251 payment$2,660
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
45.2%Corticosteroid14.1%Fluticasone Propionate100%Part D≥14 patientsHistamine-1 Receptor Antagonist14.1%Azelastine Hcl52%Levocetirizine Dihydrochloride48%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
24.3%Corticosteroid24.3%Prednisone100%Part D≥21 patientsAnti-infectives
13%Penicillins with extended spectrum6.8%Amoxicillin-Clavulanate Potass100%Part D<11 patientsMacrolide Antimicrobial6.2%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Scroll, like, diagnose? Evaluating mast cell activation syndrome information on TikTok
Allergy and Asthma Proceedings
2026 - Managing Eosinophilic Gastrointestinal Disorders: Diet, Drugs, and Dilation in the Era of Shared Decision-Making
The Journal of Allergy and Clinical Immunology In Practice
2026 - Lack of evidence for increased mast cell activation syndrome prevalence in postural orthostatic tachycardia syndrome and/or hypermobile Ehlers-Danlos syndrome
The Journal of Allergy and Clinical Immunology In Practice
2026 - 75023 Antiseizure Drug-Associated Drug Reaction with Eosinophilia and Systemic Symptoms in a U.S. Single-center Cohort
Journal of the American Academy of Dermatology
2026 - Penicillin Allergy Evaluation Pathway in a Community-Based Obstetric Setting: A Quality Improvement Study
The Joint Commission Journal on Quality and Patient Safety
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Bernard Gersh, PhD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
S. Vincent Rajkumar, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”